News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
399,330 Results
Type
Article (33988)
Company Profile (151)
Press Release (365191)
Section
Business (114800)
Career Advice (1530)
Deals (19277)
Drug Delivery (70)
Drug Development (50532)
Employer Resources (119)
FDA (8347)
Job Trends (9251)
News (196180)
Policy (18641)
Tag
Academia (2139)
Alliances (32428)
Alzheimer's disease (866)
Antibody-drug conjugate (ADC) (79)
Approvals (8337)
Artificial intelligence (120)
Bankruptcy (167)
Best Places to Work (7316)
Biotechnology (123)
Breast cancer (149)
Cancer (1129)
Cardiovascular disease (84)
Career advice (1243)
CAR-T (98)
Cell therapy (263)
Clinical research (40697)
Collaboration (448)
Compensation (78)
COVID-19 (2032)
C-suite (118)
Data (998)
Diabetes (123)
Diagnostics (3439)
Earnings (33772)
Employer resources (108)
Events (56915)
Executive appointments (380)
FDA (8844)
Funding (405)
Gene therapy (181)
GLP-1 (446)
Government (3269)
Healthcare (11317)
Infectious disease (2110)
Inflammatory bowel disease (92)
Interviews (251)
IPO (8057)
Job creations (2206)
Job search strategy (1114)
Layoffs (221)
Legal (3777)
Lung cancer (166)
Manufacturing (181)
Medical device (5416)
Medtech (5418)
Mergers & acquisitions (11420)
Metabolic disorders (339)
Neuroscience (1146)
NextGen: Class of 2025 (4541)
Non-profit (3746)
Northern California (1066)
Obesity (181)
Opinion (195)
Patents (78)
People (39124)
Phase I (12177)
Phase II (18050)
Phase III (14004)
Pipeline (435)
Postmarket research (1523)
Preclinical (4898)
Radiopharmaceuticals (149)
Rare diseases (221)
Real estate (4244)
Regulatory (12697)
Research institute (1884)
Resumes & cover letters (236)
Southern California (985)
Startups (2661)
United States (9908)
Vaccines (486)
Weight loss (137)
Date
Today (45)
Last 7 days (326)
Last 30 days (1352)
Last 365 days (21535)
2025 (1298)
2024 (21790)
2023 (24045)
2022 (32348)
2021 (34245)
2020 (32479)
2019 (29343)
2018 (22597)
2017 (19592)
2016 (19129)
2015 (22115)
2014 (18226)
2013 (16176)
2012 (14093)
2011 (15111)
2010 (12953)
Location
Africa (611)
Arizona (81)
Asia (31898)
Australia (4728)
California (2458)
Canada (934)
China (378)
Colorado (87)
Connecticut (112)
Europe (59638)
Florida (334)
Georgia (89)
Illinois (272)
Indiana (146)
Maryland (551)
Massachusetts (1928)
Michigan (114)
Minnesota (181)
New Jersey (800)
New York (761)
North Carolina (462)
Northern California (1066)
Ohio (88)
Pennsylvania (554)
South America (801)
Southern California (985)
Texas (352)
Washington State (342)
399,330 Results for "china national biotech group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Policy
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System Holdings Limited is pleased to announce that on 11 June 2024, the New Drug Application of the Group’s innovative drug methylthioninium chloride enteric-coated sustained-release tablets has been approved by the National Medical Products Administration of China.
June 18, 2024
·
7 min read
Antibody drug conjugate
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.
January 2, 2025
·
2 min read
·
Annalee Armstrong
Policy
BIO Separates from China’s WuXi AppTec Amid National Security Concerns
In a change of position as congressional scrutiny of WuXi AppTec grows, the Biotechnology Innovation Organization announced it is taking steps to separate from the China-based biotech.
March 14, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma, Italy
October 15, 2024
·
4 min read
Press Releases
Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
November 27, 2024
·
5 min read
Policy
BIOSECURE Act Could Signal a Seismic Shift for Biopharma in US and China
The BIOSECURE Act’s prohibition on doing business with China-based companies may have implications for biotech and biopharma markets on both sides of the Pacific.
July 31, 2024
·
8 min read
·
Sanjukta Mondal
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets (“Desidustat Tablets” or the “Product”) has been accepted by the National Medical Products Administration of China (NMPA).
April 23, 2024
·
4 min read
Press Releases
China’s National Medical Products Administration (NMPA) Approves VYLOY™ (zolbetuximab) for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
January 6, 2025
·
15 min read
1 of 39,933
Next
